Alignment Healthcare, Inc. (ALHC) - 2025 Annual Report Summary
Business Context and Reporting Period
This summary covers the Annual Report on Form 10-K for Alignment Healthcare, Inc. for the fiscal year ended December 31, 2025. Alignment is a next-generation Medicare Advantage platform focused on seniors, operating in 45 markets across California, North Carolina, Nevada, Arizona, and Texas. The company utilizes a proprietary technology platform, AVA, and an in-house clinical care model ("Care Anywhere") to manage member health and costs. As of December 31, 2025, the company reported 236,300 Health Plan Members, representing a 25% increase from the prior year.
Key Financial Metrics
| Metric | 2025 | 2024 | Change |
|---|---|---|---|
| Total Revenues | $3,948.7 million | $2,703.6 million | +46.1% |
| Net Loss | $(0.98) million | $(128.1) million | 99.2% Improvement |
| Income from Operations | $14.8 million | $(101.6) million | 114.5% Improvement |
| Adjusted EBITDA | $109.9 million | $1.3 million | +8,111.1% |
| Medical Benefits Ratio (MBR) | 87.5% | 88.8% | -1.3 percentage points |
| Cash and Investments | $604.2 million | $470.7 million | N/A |
| Long-Term Debt | $330.0 million | $330.0 million | 0% |
Note: The company reported a net loss of $0.98 million in 2025 compared to a net loss of $128.1 million in 2024. Adjusted EBITDA is a non-GAAP measure.
Material Changes vs. Prior Period
- Revenue Growth: Total revenues increased by $1.25 billion (46.1%), driven primarily by a 25% increase in Health Plan Membership and higher revenue per member per month due to CMS benchmark rate increases and Inflation Reduction Act (IRA) impacts.
- Profitability: The company achieved a significant turnaround in operating performance, moving from an operating loss of $101.6 million in 2024 to an operating income of $14.8 million in 2025. This was driven by improved unit economics and a lower Medical Benefits Ratio (MBR).
- Debt Refinancing: In November 2024, the company issued $330 million of 4.25% Convertible Senior Notes due 2029. Proceeds were used to repay the prior Oxford Term Loan, reducing the weighted average interest rate from 11.77% to 4.25% and lowering interest expense by $7.7 million.
- Discontinued Operations: The company discontinued its participation in the ACO REACH model as of December 31, 2025, which is expected to have an immaterial impact on financial results.
Guidance, Outlook, and Risks
Outlook and Strategy: Management expects to continue investing in the AVA platform, new market expansion, and strategic acquisitions. The company aims to leverage its "virtuous cycle" of cost savings reinvested into richer benefits to drive membership growth. As of January 1, 2026, approximately 100% of members are enrolled in plans with a 4.0 Star rating or greater.
Key Risks and Contingencies:
- Regulatory and Audit Risk: The company is subject to Risk-Adjustment Data Validation (RADV) audits by CMS. A federal court vacated a 2023 CMS rule regarding extrapolation of audit findings in September 2025, creating uncertainty regarding potential overpayment recoveries for payment years 2018-2024.
- Star Ratings: Revenue is heavily dependent on maintaining high CMS Star Ratings. Changes in methodology or failure to maintain ratings could materially impact revenue and growth.
- Geographic Concentration: Approximately 84% of members are concentrated in California, exposing the company to state-specific regulatory and economic risks.
- Debt Covenants: The company entered into a new $200 million Revolving Credit Facility in February 2026 with financial covenants requiring a maximum senior secured leverage ratio of 2.50:1.00 and minimum Consolidated EBITDA thresholds starting in 2026.
Investor Verification Checklist
- Star Rating Stability: Verify the 2026 CMS Star Ratings announcement (released in late 2025) to confirm the 4+ star status for 100% of the membership base and its impact on 2027 revenue.
- RADV Audit Exposure: Monitor the status of the litigation regarding the CMS RADV extrapolation rule and any potential financial impact from audits of payment years 2018-2024.
- Debt Covenant Compliance: Review quarterly filings to ensure compliance with the new Revolving Credit Facility covenants, specifically the minimum Consolidated EBITDA requirements starting June 30, 2026.
- Medical Cost Trends: Assess the sustainability of the improved Medical Benefits Ratio (87.5%) amidst potential inflationary pressures and the full impact of the Inflation Reduction Act on Part D costs.
- Convertible Note Conversion: Monitor the stock price relative to the $16.04 conversion price of the 4.25% Convertible Senior Notes to assess potential dilution risks.